Submitted by Anonymous (not verified) on 19 January 2024 - 11:44
Orphan designation: crisdesalazine Treatment of amyotrophic lateral sclerosis, 15/02/2023 Positive
Source:
Orphan designation: crisdesalazine Treatment of amyotrophic lateral sclerosis, 15/02/2023 Positive